TY - JOUR
KW - Epidemiology
KW - primary care
KW - Public Health
KW - statistics & research methods
KW - Substance misuse
AU - M. Piske
AU - T. Thomson
AU - E. Krebs
AU - N. Hongdilokkul
AU - J. Bruneau
AU - S. Greenland
AU - P. Gustafson
AU - M. E. Karim
AU - L. C. McCandless
AU - M. Maclure
AU - R. W. Platt
AU - U. Siebert
AU - M. E. Socias
AU - J. I. Tsui
AU - E. Wood
AU - B. Nosyk
A1 - 
AD - Epidemiology and Population Health Program, BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.; Epidemiology and Population Health Program, BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.; Epidemiology and Population Health Program, BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.; Epidemiology and Population Health Program, BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.; Centre hospitalier de l'Université de Montréal, CRCHUM, Montreal, Quebec, Canada.; Département de médecine de famille et de médecine d'urgence, Universite de Montreal, Montreal, Quebec, Canada.; Department of Epidemiology and Department of Statistics, UCLA, Los Angeles, California, USA.; Department of Statistics, UBC, Vancouver, British Columbia, Canada.; School of Population and Public Health, UBC, Vancouver, British Columbia, Canada.; Providence Health Care Research Institute, Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia, Canada.; Department of Statstics and Actuarial Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.; Department of Anesthesiology, Pharmacology and Therapeutics, UBC, Vancouver, British Columbia, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.; Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Montreal, Quebec, Canada.; Department of Health Policy and Management, Harvard University T H Chan School of Public Health, Boston, Massachusetts, USA.; Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Tirol, Austria.; Oncotyrol - Center for Personalized Cancer Medicine, Innsbruck, Austria.; BC Centre on Substance Use, Vanc(TRUNCATED)
BT - BMJ open
C5 - Opioids & Substance Use
CP - 9
DO - 10.1136/bmjopen-2019-036102
IS - 9
JF - BMJ open
LA - eng
M1 - Journal Article
PB - . Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ
PY - 2020
SN - 2044-6055; 2044-6055
SP - 2019
EP - 036102
EP - e036102+
T1 - Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada
T2 - BMJ open
TI - Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada
U1 - Opioids & Substance Use
U2 - 32912944
U3 - 10.1136/bmjopen-2019-036102
VL - 10
VO - 2044-6055; 2044-6055
Y1 - 2020
Y2 - Sep 9
ER -